Analysts Offer Predictions for Teladoc Health Q4 Earnings

Teladoc Health, Inc. (NYSE:TDOC) – Equities research analysts at Leerink Partnrs decreased their Q4 2024 earnings estimates for shares of Teladoc Health in a research note issued on Wednesday, October 30th. Leerink Partnrs analyst M. Cherny now forecasts that the health services provider will post earnings of ($0.19) per share for the quarter, down from their previous estimate of ($0.15). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.18) per share. Leerink Partnrs also issued estimates for Teladoc Health’s Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($1.09) EPS, FY2026 earnings at ($0.83) EPS and FY2027 earnings at ($0.65) EPS.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 9.40% and a negative net margin of 37.91%. The firm had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million.

A number of other research analysts also recently issued reports on the stock. Jefferies Financial Group boosted their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research report on Tuesday, September 17th. DA Davidson reduced their price target on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a research report on Thursday, August 1st. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, August 1st. JPMorgan Chase & Co. cut their price objective on shares of Teladoc Health from $16.00 to $9.00 and set a “neutral” rating for the company in a report on Monday, August 26th. Finally, Piper Sandler decreased their price objective on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. Fourteen analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $11.97.

Teladoc Health Trading Up 2.3 %

Shares of NYSE:TDOC opened at $9.21 on Monday. The business has a 50-day moving average price of $8.48 and a 200-day moving average price of $9.66. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of -1.60 and a beta of 0.90. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $22.54. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of TDOC. Robeco Institutional Asset Management B.V. boosted its position in Teladoc Health by 141.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider’s stock valued at $5,279,000 after buying an additional 337,305 shares during the period. Janney Montgomery Scott LLC grew its stake in Teladoc Health by 63.0% during the 3rd quarter. Janney Montgomery Scott LLC now owns 106,727 shares of the health services provider’s stock worth $980,000 after purchasing an additional 41,250 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in Teladoc Health during the 3rd quarter worth $111,000. Assenagon Asset Management S.A. purchased a new stake in Teladoc Health during the 3rd quarter worth about $15,801,000. Finally, International Assets Investment Management LLC boosted its stake in shares of Teladoc Health by 693.0% in the 3rd quarter. International Assets Investment Management LLC now owns 23,299 shares of the health services provider’s stock valued at $214,000 after buying an additional 20,361 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Teladoc Health

In related news, Director Thomas Mckinley bought 4,000 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $7.69 per share, with a total value of $30,760.00. Following the purchase, the director now directly owns 39,077 shares of the company’s stock, valued at $300,502.13. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, COO Michael Willem Waters sold 4,218 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the completion of the transaction, the chief operating officer now owns 78,309 shares of the company’s stock, valued at approximately $560,692.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Thomas Mckinley bought 4,000 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the transaction, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 35,051 shares of company stock valued at $257,565. Corporate insiders own 0.95% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.